Form 4: Itron Director Receives Stock Grant
Insider Transaction
Sanjay Mirchandani, a Director at Itron, Inc., received a grant of 621 shares of common stock as part of his quarterly compensation.
Summary
- Sanjay Mirchandani, a Director of Itron, Inc., was granted 621 shares of common stock on July 1, 2026.
- This grant is part of the quarterly compensation provided to independent board members for their service.
- The shares were acquired at no cost, as indicated by a price of $0.
- Following this transaction, Mr. Mirchandani beneficially owns 6,824 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine compensation event for a director rather than a significant strategic or financial development.
Positives
- Director compensation in the form of stock aligns the interests of the board with shareholders.
- The grant of 621 shares represents a continued investment in the company by a key insider.
Future Outlook
This filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that stock grants to directors are a common practice in the technology and utility sectors, including companies like Itron, Inc., to ensure alignment between board members and shareholders.
Stakeholder Impact
- Shareholders: The stock grant reinforces the alignment of director interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 07/01/2026 | Transaction Date (Grant of common stock) |
| 07/02/2026 | Date of signature on the filing |
Keywords
Itron Inc, ITRI, Form 4, Insider Transaction, Stock Grant, Director Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.